XTALPI(02228),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02228 XTALPI

Closed 03-19 16:08:15

9.570

-0.520

-5.15%

High9.930	Low9.500	Vol47.72M
Open9.850	D1 Closing10.090	Amplitude4.26%
Mkt Cap41.18B	Tradable Cap41.18B	Total Shares4.30B
T/O460.83M	T/O Rate1.11%	Tradable Shares4.30B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"XTALPI","latestPrice":9.57,"timestamp":1773907695003,"preClose":10.09,"halted":0,"volume":47715792,"delay":0,"changeRate":-0.0515361744301288,"floatShares":4303000000,"shares":4303000000,"eps":-0.8962402700120597,"marketStatus":"Closed","change":-0.52,"latestTime":"03-19 16:08:15","open":9.85,"high":9.93,"low":9.5,"amount":460827657,"amplitude":0.042616,"askPrice":9.57,"askSize":8000,"bidPrice":9.56,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-0.05672406772228226,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":5,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":10.09,"openAndCloseTimeList":[[1773883800000,1773892800000],[1773896400000,1773907200000]],"volumeRatio":0.894318,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"1184677656","title":"XTALPI Shares Surge Over 4% as First Annual Profit in 2025 Highlights Value of Unique AI Drug Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1184677656","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184677656?lang=en_us&edition=fundamental","pubTime":"2026-03-16 14:30","pubTimestamp":1773642623,"startTime":"0","endTime":"0","summary":"XTALPI (02228) rose more than 4% during trading, reaching HK$9.88 per share with a turnover of HK$383 million. The company previously issued a profit alert, projecting revenue of no less than RMB 780...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3923f54d12d0c12982608f5f8a99e8da","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK4588","VXUS","BK1617","BK1141","BK1191","02228","BK1574","BK4585"],"gpt_icon":0},{"id":"2619773191","title":"Xtalpi Holdings Ltd. to Release Full-Year 2025 Annual Results After Hong Kong Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2619773191","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619773191?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:49","pubTimestamp":1773402595,"startTime":"0","endTime":"0","summary":"Xtalpi Holdings Ltd. to Release Full-Year 2025 Annual Results After Hong Kong Market Close               XtalPi said it will report annual results for the year ended Dec. 31, 2025 on March 25, 2026, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL47d7kJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2618951882","title":"BRIEF-XtalPi Holdings Appoints Zhou Feiran As Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951882","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618951882?lang=en_us&edition=fundamental","pubTime":"2026-03-10 22:37","pubTimestamp":1773153426,"startTime":"0","endTime":"0","summary":"BRIEF-XtalPi Holdings Appoints Zhou Feiran As Chief Financial OfficerMarch 10 (Reuters) - XtalPi Holdings Ltd 2228.HK:APPOINTS ZHOU FEIRAN AS CHIEF FINANCIAL OFFICERFurther company coverage: 2228.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2618893955","title":"XtalPi Names CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2618893955","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618893955?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:17","pubTimestamp":1773148645,"startTime":"0","endTime":"0","summary":"Pharmaceutical research firm XtalPi (HKG:2228) appointed Zhou Feiran as its CFO effective Tuesday, according to a same-day Hong Kong bourse filing.Zhou worked at J.P. Morgan from 2020 to 2026, with his last position being an executive Director in the Global Healthcare Investment Banking division.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"1138528948","title":"XTALPI (02228) Names Zhou Feiran as Chief Financial Officer, Effective 10 March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1138528948","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138528948?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:03","pubTimestamp":1773140585,"startTime":"0","endTime":"0","summary":"XtalPi Holdings Limited (stock code: 02228) has appointed Mr. Zhou Feiran as Chief Financial Officer, effective 10 March 2026, according to a voluntary announcement released by the Board of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"gpt_icon":0},{"id":"1136708781","title":"XTALPI Appoints Feiran Zhou as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=1136708781","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136708781?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:58","pubTimestamp":1773140301,"startTime":"0","endTime":"0","summary":"XTALPI (02228) announced that Mr. Feiran Zhou has been appointed as the company's Chief Financial Officer, effective March 10, 2026.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2618931784","title":"Xtalpi Holdings Ltd - Appoints Zhou Feiran as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931784","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618931784?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:53","pubTimestamp":1773140031,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2618931737","title":"XtalPi appoints Zhou Feiran as CFO effective March 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931737","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618931737?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:53","pubTimestamp":1773140030,"startTime":"0","endTime":"0","summary":"XtalPi appointed Zhou Feiran as chief financial officer, effective 10 March 2026. Zhou previously worked at J.P. Morgan, most recently as an executive director in global healthcare investment banking.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL1J7bS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"1109360417","title":"Guotai Haitong: AI-Driven Drug Development Advances with Accelerated MNC Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=1109360417","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109360417?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:36","pubTimestamp":1773045398,"startTime":"0","endTime":"0","summary":"Guotai Haitong has released a research report stating that as artificial intelligence becomes increasingly integrated across target discovery, molecule generation, clinical trial design, and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK0012","BK0276","601211","BK1574","BK1617","01477","02611","BK1147","BK0184","BK0201","BK0028","BK0188","BK1576","BK1191","01873","BK1564","02228","BK0183","BK1141"],"gpt_icon":0},{"id":"1123853786","title":"Numans Acquires 2 Million Shares in Xtalpi","url":"https://stock-news.laohu8.com/highlight/detail?id=1123853786","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123853786?lang=en_us&edition=fundamental","pubTime":"2026-03-04 19:10","pubTimestamp":1772622617,"startTime":"0","endTime":"0","summary":"Numans (02530) announced that on March 4, 2026, the group purchased a total of 2 million shares of Xtalpi on the open market for a total consideration of HK$19.73 million, inclusive of stamp duty and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1617","02228","02530","BK1207"],"gpt_icon":0},{"id":"1116680103","title":"XtalPi (02228) Announces February 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1116680103","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116680103?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:04","pubTimestamp":1772615045,"startTime":"0","endTime":"0","summary":"XtalPi (02228) reported that its authorized share capital remained at US$1.00 million in February 2026, consisting of 100.00 billion ordinary shares at a par value of US$0.00001 each. The number of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"gpt_icon":0},{"id":"1174457310","title":"Techtronic Industries Reports 6.8% Net Profit Growth to $1.2 Billion for 2025, Declares Final Dividend of 132 HK Cents Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1174457310","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174457310?lang=en_us&edition=fundamental","pubTime":"2026-03-04 09:16","pubTimestamp":1772587013,"startTime":"0","endTime":"0","summary":"【Major Corporate Announcements】China Biologic (01177) has entered into an exclusive licensing agreement with Sanofi for rovatcitinib. Degron Therapeutics (06996) has reached a global exclusive...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1183","IE00B0169N27.USD","IE00B031J352.USD","IE00BYTNYN87.SGD","BK1553","BK1592","LU0227179875.USD","01112","LU2125910500.SGD","00041","00669","LU0084288322.USD","BK1521","LU0877626530.USD","SG9999000327.SGD","IE0008368411.USD","SG9999001689.USD","SG9999011746.SGD","LU1119993845.HKD","LU2045819591.USD","LU1102505762.USD","IE00B12V2V27.USD","LU0149534421.HKD","LU2488822045.USD","BK4585","BK1597","LU0048597586.USD","LU2177674079.SGD","IE0031814852.USD","BK1534","IE00B031HY20.USD","LU0048388663.USD","VT","BK1216","IE0008368742.USD","IE0009570106.USD","LU0106259558.USD","BK1141","LU0607220059.USD","IE0008369823.USD","LU2008162690.USD","SG9999014674.SGD","VXUS","LU2242644610.SGD","BK4588","LU0327786744.USD","LU0261947096.USD","IE0034224299.USD","LU0229945570.USD","LU0251144936.SGD","IE00B031HW06.USD","01208","BK1594","BK1617","02228","IE00BYQNZ168.SGD","LU0205439572.USD","LU0543330566.HKD","LU2039709279.SGD","BK1190","LU0572944931.SGD","BK1237"],"gpt_icon":0},{"id":"2616373406","title":"Assessing XtalPi Holdings (SEHK:2228) Valuation After Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2616373406","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616373406?lang=en_us&edition=fundamental","pubTime":"2026-03-04 01:37","pubTimestamp":1772559477,"startTime":"0","endTime":"0","summary":"Intro\nXtalPi Holdings (SEHK:2228) has been drawing attention after recent share price swings, with the stock showing a decline over the past month but a positive total return over the past 3 months.\nSee our latest analysis for XtalPi Holdings.\nThat recent 21.03% 1 month share price decline, alongside a 10.51% 7 day pullback from the latest HK$9.54 close, contrasts sharply with a 57.69% 1 year total shareholder return. This suggests shorter term momentum is fading while longer term holders...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1141","DCF","BK1617","02228"],"gpt_icon":0},{"id":"1188437441","title":"Who Emerges as the Leader in Hong Kong's AI Application Sector?","url":"https://stock-news.laohu8.com/highlight/detail?id=1188437441","media":"Stock News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188437441?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:40","pubTimestamp":1772548852,"startTime":"0","endTime":"0","summary":"Nvidia founder Jensen Huang has previously highlighted three core areas for AI application implementation: large language models, embodied AI, and AI for Science. Since the beginning of the year, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1617","BK4588","02228","VXUS","BK1141","VT"],"gpt_icon":0},{"id":"2616341749","title":"XtalPi Forecasts Full-Year Profit for First Time in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2616341749","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616341749?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:34","pubTimestamp":1772537659,"startTime":"0","endTime":"0","summary":"XtalPi  expects an attributable profit of 100 million yuan for the year 2025, compared with an attributable loss of 1.52 billion yuan a year prior, according to a Tuesday Hong Kong bourse filing.This is reportedly the first instance of the pharmaceutical research firm recording a full-year profit.The firm attributed the forecast to a 193% rise in revenue, an increase in net fair value gains on financial assets measured at fair value through profit or loss, and the absence of a fair value loss of convertible redeemable preferred shares as was seen in 2024.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2616450293","title":"BRIEF-XtalPi Sees Increase In Group's Revenue To Not Less Than RMB780 Million For FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2616450293","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616450293?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:23","pubTimestamp":1772533385,"startTime":"0","endTime":"0","summary":"BRIEF-XtalPi Sees Increase In Group's Revenue To Not Less Than RMB780 Million For FYMarch 3  - XtalPi Holdings Ltd 2228.HK:SEES INCREASE IN GROUP'S REVENUE TO AMOUNT OF NOT LESS THAN RMB780 MILLION FOR FY2025EXPECTS PROFIT ATTRIBUTABLE NOT LESS THAN RMB100 MILLION FOR FYFurther company coverage: 2228.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"1190639451","title":"XTALPI Issues Profit Alert, Anticipates First Full-Year Profit with Over 100 Million Yuan Net Income in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1190639451","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190639451?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:09","pubTimestamp":1772532596,"startTime":"0","endTime":"0","summary":"XTALPI (02228) has announced that the group expects both its after-tax profit and profit attributable to equity shareholders to reach no less than RMB 100 million in 2025. This represents a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2616345815","title":"Xtalpi Holdings Sees Increase in Group's Revenue to Amount of Not Less Than RMB780 Mln for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2616345815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616345815?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:01","pubTimestamp":1772532103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2616022343","title":"XtalPi forecasts FY2025 net profit of at least RMB100 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616022343","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616022343?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:00","pubTimestamp":1772532055,"startTime":"0","endTime":"0","summary":"XtalPi Holdings Ltd. issued a positive profit alert, expecting to swing to a full-year net profit of not less than RMB100 million for FY2025, compared with a net loss after tax of about RMB1,514.9 million in FY2024. The company forecasts FY2025 revenue of at least RMB780 million, up at least 193% from RMB266.4 million a year earlier, alongside net fair value gains on FVTPL financial assets of not less than RMB500 million versus RMB25.3 million in FY2024, and no repeat of the RMB875.4 million fair value loss on convertible redeemable preferred shares recorded in FY2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Servi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL6qZjRx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2616359323","title":"XtalPi and ReviR Dose First Participant in Phase 1 Trial of RTX-117 for CMT and VWM","url":"https://stock-news.laohu8.com/highlight/detail?id=2616359323","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616359323?lang=en_us&edition=fundamental","pubTime":"2026-03-02 23:30","pubTimestamp":1772465435,"startTime":"0","endTime":"0","summary":"XtalPi Holdings Ltd. reported that ReviR Therapeutics has dosed the first participant in a Phase 1 randomized, double-blind, placebo-controlled, dose-escalation trial of RTX-117, an investigational small molecule for Charcot-Marie-Tooth disease and Vanishing White Matter disease. The study, being conducted in China, is designed to assess safety, tolerability, pharmacokinetics and pharmacodynamics in healthy participants, with the aim of supporting future patient studies. The announcement did not include clinical results; results are expected to be generated in the future as the trial progresses.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL5zKlL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02228","BK1617"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":-0.1031},{"period":"3month","weight":0.0944},{"period":"6month","weight":-0.0436},{"period":"1year","weight":0.4926},{"period":"ytd","weight":0.0666}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":-0.0255},{"period":"3month","weight":0.0207},{"period":"6month","weight":-0.0196},{"period":"1year","weight":0.0519},{"period":"ytd","weight":0.0154}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"XtalPi Holdings Ltd, formerly QuantumPharm Inc, is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. The drug discovery solutions business is engaged in providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The intelligent automation solutions business is engaged in the provision of solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"XTALPI","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XTALPI(02228),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest XTALPI(02228) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"XTALPI,02228,XTALPI股票,XTALPI股票老虎,XTALPI股票老虎国际,XTALPI行情,XTALPI股票行情,XTALPI股价,XTALPI股市,XTALPI股票价格,XTALPI股票交易,XTALPI股票购买,XTALPI股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XTALPI(02228),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest XTALPI(02228) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}